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Abstract 26 
The endothelium plays an important role in cardiovascular regulation, from blood flow, 27 
to platelet aggregation, immune cell infiltration and demargination. A dysfunctional 28 
endothelium leads to the onset and progression of cardiovascular disease (CVD). The 29 
aging endothelium displays significant alterations in function, such as reduced 30 
vasomotor functions and reduced angiogenic capabilities. This could be partly due to 31 
elevated levels of oxidative stress and reduced endothelial cell turnover. Circulating 32 
angiogenic cells, such as endothelial progenitor cells (EPCs) play a significant role in 33 
maintaining endothelial health and function, by supporting endothelial cell 34 
proliferation, or via incorporation into the vasculature and differentiation into mature 35 
endothelial cells. However these cells are reduced in number and function with age, 36 
which may contribute to the elevated CVD risk in this population. However, lifestyle 37 
factors, such as exercise, physical activity obesity, an dietary intake of omega-3 38 
polyunsaturated fatty acids, nitrates, and antioxidants, significantly affect the number 39 
and function of these circulating angiogenic cells. This review will discuss the effects 40 
of advancing age on endothelial health and vascular regenerative capacity, as well as 41 
the influence of diet, exercise, and obesity on these cells, the mechanistic links and the 42 
subsequent impact on cardiovascular health.  43 
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The Aging Endothelium 51 
 52 
The inner lining of all blood vessels consists of a single monolayer of endothelial cells. 53 
These cells play a key role in diffusion and transport of nutrients, gases from the blood 54 
to surrounding tissues, as well as being central to the control of blood flow via the 55 
endothelium’s ability to secrete vasoactive substances, such as nitric oxide (NO) and 56 
prostacyclin (PGI2). The endothelium also plays a role in our immune system, whereby 57 
it controls the adhesion, rolling and trans-endothelial migration of leukocytes to sites 58 
of tissue damage and/or infection. The maintenance of the endothelium is key for 59 
optimal health, and specifically cardiovascular health, as endothelial dysfunction often 60 
precedes cardiovascular disease (CVD). 61 
 62 
Advancing age is associated with endothelial dysfunction (1-4), which is highly 63 
predictive of cardiovascular event risk and mortality (5, 6). Aging is also associated 64 
with increased endothelial susceptibility to apoptosis (7). These aging effects are 65 
potentially due to elevated levels of vascular tissue oxidative stress (8) which may 66 
contribute to uncoupling of endothelial NO synthase (eNOS) (9), key for NO 67 
bioavailability via the conversion of L-arginine to NO. Elevated levels of pro-oxidant 68 
free radicals, such as superoxide, have been found in vascular tissue from aged 69 
compared to younger rats (8). This elevated production of superoxide leads to the 70 
formation of peroxynitrite (10), which has been observed to stimulate the uncoupling 71 
of eNOS (9).  72 
 73 
A recent meta-analysis also demonstrated that peripheral vascular resistance is also 74 
elevated in aging populations, with negative alterations in smooth muscle function in 75 
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older compared with younger men and women (11). Upon specific dilator 76 
administration, such as nitroglycerine or sodium nitroprusside, older adults display 77 
reduced dilator capacity, indicative of reduced smooth muscle function. This has been 78 
attributed to decreased expression of soluble guanylyl cyclase in smooth muscle cells 79 
(12), attenuating the cell’s ability to relax, subsequently leading to impaired 80 
vasodilation and peripheral blood flow. It is clear that the deleterious impact of aging 81 
on vascular resistance is due to, in part, alterations in endothelial NO release, as well 82 
as smooth muscle function, but there are also data to suggest that changes in vascular 83 
resistance due to age may be related to abnormal responses to the metaboreflex (13). 84 
  85 
In addition, angiogenic capabilities are reduced with advancing age in both mice (14-86 
17) and human studies (18), which may contribute to the increased CVD risk amongst 87 
the elderly (19, 20) due to insufficient repair or replacement of damaged endothelial 88 
cells. This is highlighted in animal models, with the ability to re-vascularisation in 89 
response to vascular trauma or occlusion is reduced with age (21, 22), suggestive of an 90 
impaired endothelial regenerative capacity. 91 
 92 
Endothelial Regeneration and Advancing Age 93 
 94 
It was previously thought that endothelial cell turnover was wholly maintained by the 95 
proliferation of vascular resident endothelial cells. However, in 1997, researchers 96 
discovered a circulating cell subset which had the ability to differentiate into mature 97 
endothelial cells in vitro (23), and these researchers termed these cells ‘endothelial 98 
progenitor cells’ (EPCs). These cells were human CD34+ cells, and after a period of 7 99 
days in culture expressed mature endothelial cell markers (VEGFR2, CD31, E-selectin, 100 
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eNOS). These cells could also form tubes on fibronectin-coated plates in vitro (23, 24). 101 
A number of studies have shown that such EPCs have the ability to stimulate 102 
neovascularization in rodent (25, 26) and human models (21, 27). However, the origin 103 
of these cells has been widely debated, Some studies show that these CD34+ 104 
vasculogenic progenitors are derived from the bone marrow using tracking models (25, 105 
26), however, there is some evidence to suggest that progenitor cells within tumour 106 
vasculature did not derive from bone marrow (28).  107 
 108 
These cells may maintain endothelial integrity and health via differentiating into mature 109 
endothelial cells, therefore replacing damaged or apoptotic endothelial cells, or via 110 
paracrine means by secreting vasculogenic growth factors such as VEGF, IL-8 (29). 111 
However, via cellular tracking, EPCs from humans transplanted into a mouse hindlimb 112 
ischemic model were found to stimulate neovascularisation and were later found 113 
incorporated in the injured vasculature (21), suggesting that the integrity of the 114 
endothelium may be partly dependent upon the reparative capacity of such EPCs (30). 115 
It is now generally accepted that circulating EPCs that act in a paracrine manner, or as 116 
genuine endothelial precursors, are phenotypically distinct, with the former expressing 117 
CD34, CD133, being CD45bright as well as expressing an endothelial cell surface 118 
antigen, such as VEGFR2 or CD31 (29, 31). Circulating CD34+ progenitors that have 119 
been shown to have potential to differentiate into mature endothelial cells express 120 
CD34, dimly express CD45 (CD45dim), lack CD133 expression whilst also expressing 121 
endothelial cell surface antigens (29, 31). These two distinct phenotypes of EPCs have 122 
been termed ‘early’ and ‘late’ outgrowth endothelial cells because of the time of their 123 
appearance in culture. Early outgrowth endothelial cells (EOC) appear early in culture, 124 
and function primarily via paracrine means, whereas late outgrowth endothelial cells 125 
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(LOC) appear late in culture and have the ability to differentiate into endothelial cells 126 
in vitro (29).  Together, both EOC and LOC can be considered as contributing to 127 
maintenance of endothelial cell integrity, just via differing means. For this review, EOC 128 
and LOC will be grouped together as ‘EPCs’. For more in depth review on EPC subsets 129 
and physiological functions, see review by Medina et al. (32). 130 
 131 
Circulating EPCs are rare in peripheral blood, often making up to 0.05% of all 132 
mononuclear cells in humans (33), however, despite their small number, they remain 133 
independent predictors of endothelial function (34, 35), and mortality in patient 134 
populations (36, 37), with lower numbers often reflecting endothelial dysfunction and 135 
heightened cardiovascular mortality risk. Many studies have demonstrated lower 136 
circulating number and function of EPCs in vascular-related disease states (such as 137 
stroke, cerebrovascular disease, atherosclerosis) compared to age-matched healthy 138 
controls (30, 34, 35, 38-47). The reduction in these cells in the circulation may be due 139 
to an exhaustion of the bone marrow progenitor cell pool due to increased need for 140 
vascular repair (46), and increased apoptosis of these cells (43, 48).  141 
 142 
Older adults display reduced number and function of circulating EPCs (21, 27, 49-54) 143 
which may play a role in the increased CV risk with advancing age (20). Advancing 144 
age is linked with reduced vascular repair mechanisms, as observed by Torella et al. 145 
(22) who found that endothelial repair after balloon injury in a rat model was 146 
significantly reduced in older vs. younger rats. Our laboratory has shown that older 147 
adults display significantly reduced circulating angiogenic cells compared to younger 148 
counterparts, independent of several cardiometabolic risk factors (e.g. fasting glucose, 149 
triglycerides, LDL, HDL) (54). Thijssen et al. (49) also observed reduced circulating 150 
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CD34+VEGFR2+ EPCs in old (67-76 years) vs. younger men (19-28 years), but the 151 
reasons for these differences remain unclear.  152 
 153 
EPC function appears to be affected also by advancing age. EPC migration, 154 
proliferation and tube forming capacity is reduced in older individuals (21, 27, 50-53, 155 
55-57). In an elegant study, Xia, Yang (21) took human EPCs from young and older 156 
adults, and investigated their re-endothelialization ability in a hindlimb ischemia model 157 
in mice, and found that transplanted EPCs from older adults did not stimulate 158 
endothelialization or recovery of perfusion to the same extent as transplanted EPCs 159 
from younger individuals. The underlying mechanisms explaining the age-related 160 
reduction in both EPC number and function are still unclear. It is highly likely that a 161 
combination of age-related increases in oxidative stress (58), bone marrow niche 162 
alterations (59), telomere shortening (56) and other circulating factors (60) may explain 163 
these observations.  164 
 165 
Together, this data strongly suggests a deleterious effect of aging on EPC number and 166 
function (see Table 1 and Figure 1 for summary of the effect of age on EPC number 167 
and function), and studies have investigated the effect of pharmacological interventions 168 
to improve EPC number and function in at-risk individuals (61-64). However, as a 169 
preventative measure, lifestyle modifications may hold significant promise as these 170 
cells are significantly affected by lifestyle factors such as smoking (65, 66), physical 171 
activity/inactivity, and exercise (67-69).  172 
[INSERT TABLE 1 HERE] 173 
[INSERT FIGURE 1 HERE] 174 
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In this review we will cover the influence of various dietary factors on EPC number 175 
and function, and the potential negative impact obesity has on EPCs, finally reviewing 176 
the literature on dietary strategies to induce weight loss, and the subsequent impact this 177 
may have on circulating EPCs to promote cardiovascular health in an at-risk, aging 178 
population. 179 
 180 
Nitric Oxide-Mediated Mobilization of EPCs: Potential for Dietary Nitrate 181 
 182 
Recently, the therapeutic role of dietary nitrate (in the form of beetroot [as a root 183 
vegetable or in concentrated form], watercress, and spinach) in vascular health has been 184 
explored due to the potential to modulate NO bioavailability. Acute and chronic 185 
supplementation of inorganic dietary nitrate has been shown to improve arterial 186 
vasomotor function (70-72), reduce blood pressure in healthy young (73) and older 187 
subjects (72) and reduce arterial stiffness as measured via pulse wave velocity (72). The 188 
potential mechanisms by which dietary nitrate may improve these vascular health 189 
markers include an increase in NO bioavailability. Once ingested, nitrate is reduced to 190 
nitrite in the mouth and gut (74), where it can be absorbed into the circulation. 191 
Elevations of plasma nitrate and nitrite are observed as quickly as within 2 hours of 192 
ingestion of a high concentrated nitrate dose (in the form of beetroot juice) which 193 
subsequently results in significant alterations in both systolic and diastolic blood 194 
pressure within this timeframe (75, 76).  195 
 196 
Recent epidemiological evidence suggests that nitrate has a strong positive effect on 197 
human health. In 2017, researchers found that plasma nitrate was inversely associated 198 
with all-cause mortality in the Offspring cohort of the Framingham Heart Study (77). 199 
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Interestingly, there was no such association with incidence CVD mortality, with their 200 
data also suggesting that the effect of plasma nitrate on mortality was attenuated after 201 
controlling for glomerular filtration rate, suggestive of a protective effect on renal 202 
function. In mice, 3 months of nitrate deficient diet resulted in greater visceral 203 
adiposity, reduced glycaemic control and vascular function (78). Levels of eNOS were 204 
downregulated in the mice fed with the nitrate-depleted diet which may contribute to 205 
the reduced vascular function in these mice.  206 
 207 
In addition to having impact on endothelial function via modulating NO bioavailability, 208 
dietary nitrate may also impact on circulating angiogenic cells. The mobilization of 209 
EPCs has been shown to be eNOS dependent (79), and additionally NO itself can 210 
mobilise these cells via activation of bone marrow matrix metalloproteinase-9 (80) 211 
which itself cleaves membrane-bound Kit ligand from bone marrow stromal cells, 212 
leading to the extravasation of progenitor cells into the circulation (81). This led 213 
researchers to investigate if dietary nitrate can influence progenitor cell number and 214 
function. Indeed, the ingestion of a single dose of nitrate-rich solution led to the 215 
mobilisation of CD34+VEGFR2+ and CD133+VEGFR2+ cells into the circulation 216 
within 1 hour in healthy humans, which was accompanied by increases in stem cell 217 
factor (SCF) and stromal-derived factor-1α (SDF-1α) (82). Within the same study this 218 
effect was abolished with the co-infusion of a NO scavenger (cPTIO) in a mouse model. 219 
A chronic supplementation study in hypercholesterolemic rabbits found that 220 
supplementing with L-arginine, the precursor to NO synthesis, led to a significantly 221 
greater number of circulating CD34+VEGFR2+ EPCs than control 222 
hypercholesterolemic rabbits (83). This data has been supported elsewhere, with a diet 223 
supplemented with L-arginine, in combination with exercise training, resulted in 224 
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elevations in EPCs in mice, compared to exercise alone which also resulted in increases 225 
in circulating EPCs (84). 226 
 227 
Together, these data suggest a potential role for nitrate diets to potentially mobilize 228 
EPCs from the bone marrow to maintain or improve vascular health. However, there is 229 
paucity of data in humans, and in clinical conditions whereby such an intervention may 230 
have greater health implications. Future research must also include data on functionality 231 
of such EPC populations to determine potential cellular effects outside of the bone 232 
marrow mobilisation itself. 233 
   234 
Omega-3 235 
 236 
Omega-3 polyunsaturated fatty acids (PUFA) have recently emerged as potential 237 
vascular protective foods. Omega-3 fatty acids, such as eicosapentaenoic acid (EPA) 238 
and docosahexaenoic acid (DHA), are primarily found in oily fish, but also found in 239 
plant sources, such as nuts and seeds. Epidemiological data suggested that the ingestion 240 
of omega-3 fatty acids may reduce CVD rates (85). This study observed a 10x reduced 241 
risk of myocardial infarction amongst Greenland Inuits compared to a Danish 242 
population, which may be due to their vastly different intake of omega-3 fatty acids per 243 
day (14g vs. 3g) (86). However, clinical trial data of the impact of omega-3 fatty acids 244 
on cardiovascular and all-cause mortality are mixed with regards to the efficacy of these 245 
fatty acids on health (87-90). 246 
 247 
Omega-3 fatty acids may influence health through affecting plasma membrane 248 
phospholipid composition, which may impact cell signalling via altering membrane 249 
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fluidity, lipid raft structure and substrate availability (91, 92). DHA upregulates eNOS 250 
phosphorylation in human endothelial cells in vitro (93) and suppresses cytokine-251 
induced endothelial adhesion molecule expression (94), suggestive of a potent vascular 252 
benefit. There is also evidence that both EPA and DHA can attenuate H2O2-induced 253 
DNA damage in human aortic endothelial cells via reductions in intracellular oxidative 254 
stress as a result of upregulated levels of heme oxygenase-1, thioredoxin reductase 1, 255 
and manganese superoxide dismutase (95). However, the evidence for a strong effect 256 
on vascular endothelial function is absent in human studies (96).  257 
 258 
Interestingly, omega-3 fatty acids may play a role in angiogenesis. Recent studies 259 
showed that in aged mice, a diet rich in omega-3 PUFA was associated with improved 260 
post-ischemic stroke angiogenesis and neurogenesis (97), and transgenic mice that 261 
overproduce n-3 PUFAs were protected against ischemic stroke, displayed enhanced 262 
post-ischemic angiogenesis and greater survival than control mice (98). Potential 263 
contributions to the augmented revascularization may be due to enhanced VEGF 264 
signalling in resident endothelial cells (98) or via mobilization of angiogenic cells to 265 
the infarct zone and manipulation of their angiogenic functions. In an in vitro-only 266 
study, incubation with EPA or DHA significantly improved EPC colony forming units 267 
and tube formation of these regenerative cells in vitro (99). However, migratory 268 
capacity of these cells, reflective if ability to migrate to ischemic tissue in vivo, only 269 
improved upon co-incubation with both EPA+DHA (99). These results were somewhat 270 
supported by Tikhonenko et al.  (100) who found that supplementing with DHA in a 271 
type 2 diabetes mouse model rescues EPCs in blood and bone marrow, as well as 272 
displaying protective effect of DHA on EPC migration in vitro further suggestive of 273 
protective effect of omega-3 fatty acids on EPC number and angiogenic function (100, 274 
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101). In the only two human supplementation studies, an eight- and six- week fish oil 275 
supplementation period significantly increased number of circulating CD34+VEGFR2+ 276 
cells (102, 103), and also significantly reduced markers of vascular damage and platelet 277 
aggregation (103). These changes in EPCs were not accompanied by changes in 278 
circulating biochemical markers of vascular health, such as total cholesterol, LDL, 279 
HDL, triglycerides or fasting glucose (103), suggestive of a direct effect on cellular 280 
survival (104) and/or mobilization. These effects of omega-3 fatty acids on EPCs are 281 
not long-lasting, as six weeks after cessation of the omega-3 fatty acid-rich diet, 282 
circulating EPCs returned to pre-diet levels (102). 283 
 284 
These data strongly suggest despite not having clear benefits on vascular function in 285 
humans, omega-3-rich diets may augment the number and function of circulating EPCs 286 
which may have clinical significance for endothelial repair, and may be of interest to 287 
older adults who display such EPC dysfunction. 288 
 289 
Mediterranean Diets 290 
 291 
Mediterranean diets typically contain high levels of olive oil, fruits, nuts, vegetables 292 
and cereals, and often include moderate intake of fish and poultry, with low intake of 293 
red and processed meats. There is strong evidence that supports the use of a diet rich in 294 
olive oil, fruit, nuts, vegetables and low in red meats for the prevention of CV events 295 
and CVD (105, 106), with a meta-analysis indicating a reduced risk ratio for CV 296 
incidence or mortality, cancer incidence or mortality, and neurodegenerative disease 297 
incidence with for those adhering to such a diet (106). The proposed mechanism for 298 
such effect on cardiovascular health may be due to specific effects on reducing 299 
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atherosclerosis-associated inflammation (107), such as circulating high sensitivity C-300 
reactive protein (CRP) and interleukin-6 (IL-6) (107, 108). After 2 years of a 301 
Mediterranean diet, an improvement in endothelial function was observed, as well as a 302 
reduction in carotid intima-media thickness (cIMT)  (107) and insulin sensitivity also 303 
improved significantly (107, 108). 304 
 305 
One year of a ‘Mediterranean’ diet, rich in olive oil, fruit, vegetables, fish, legumes, 306 
and wholegrain foods  improved vascular conductance in a group of older adults (mean 307 
age: 56 years) more so than a year-long exercise training intervention (109), indicating 308 
that the diet could be a beneficial strategy for preventing CV issues with aging, once 309 
again, potentially due to reductions in inflammatory biomarkers or improvement in 310 
antioxidant status (110, 111). Considering also, the high omega-3 content of such a diet, 311 
potential vascular health benefits of a Mediterranean diet may be also due to the 312 
reductions in oxidative stress via the biological effects of EPA and DHA. 313 
 314 
Several studies have investigated the impact of these types of diet on circulating EPCs 315 
in a variety of human populations (metabolic syndrome, type 2 diabetics, and the 316 
elderly), showing significant promise in modulating endothelial repair capacity. In 317 
those with type 2 diabetes mellitus, 4 years of the diet resulted in a significant increase 318 
in CD34+VEGFR2+ and CD34+CD133+VEGFR2+ EPCs at both year 2 and year 4 319 
timepoints (108). There was an absence of any change in these markers of endothelial 320 
repair capacity in a parallel low fat diet. The elevations in EPCs were concomitantly 321 
observed alongside reductions in inflammatory biomarkers CRP, and reductions in 322 
cIMT. Interestingly, the increases in EPCs were inversely associated with cIMT in the 323 
Mediterranean diet group (108). After only 8 weeks, such a diet resulted in significant 324 
 14 
increases in CD34+VEGFR2+ EPCs in individuals with the metabolic syndrome, 325 
however, this increase was superseded by combination of diet plus exercise intervention 326 
over the same duration (112). 327 
 328 
In an aging population of both men and women (>65yrs), a 4 week dietary intervention 329 
resulted in >100% increases in circulating CD34+CD133+VEGFR2+ EPCs in 330 
participants undertaking a diet rich in olive oil, vegetables, and fish, as opposed to a 331 
low carbohydrate diet enriched with PUFA, and a significant reduction in endothelial 332 
microvesicles (indicative of endothelial damage and/or activation) (113). Once again, 333 
these changes were irrespective of cardiometabolic risk factor changes. Cesari et al. 334 
(114) found that circulating number of EPCs 335 
(CD34+VEGFR2+/CD34+CD133+VEGFR2+) were related to olive oil consumption, 336 
dietary vegetable servings and ‘Mediterranean diet score’ (a score of adherence to a 337 
Mediterranean diet devised by Panagiotakos et al. (115)) in a large population of 338 
nonagenarians. However, longer duration interventions in this aging population, as well 339 
as functional assessment of endothelialization are lacking and thus are required to fully 340 
elucidate the impact of such diet on endothelial regeneration and repair. It must also be 341 
acknowledged that it is difficult to attribute the improvements in these vascular 342 
reparative cells to a certain aspect of the diet due to the wide variety of components of 343 
the diet. 344 
 345 
Physical Activity and Exercise Effects on Endothelial Progenitor Cells 346 
 347 
Exercise and physical activity has potent cardiovascular effects. These include 348 
prevention or reversal of plaque formation in the vasculature (116, 117), improved 349 
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endothelial function (118-121), and angiogenesis (122-124) in a variety of human 350 
populations. Single bouts of exercise have the remarkable ability to stimulate the 351 
mobilization of EPCs from peripheral tissues such as the bone marrow, into the 352 
circulation for up to 72 hours post-exercise (54, 68, 125-129). However, some studies 353 
have failed to show any changes in circulating EPCs in the post-exercise recovery 354 
period (49, 130). The response to exercise is duration and intensity-dependent (127), 355 
but also dependent on human population investigated, with the evidence showing those 356 
with CVD (131-133), and older adults (54) display an attenuated response. EPC 357 
mobilization in response to exercise is said to be due to changes in circulating 358 
chemoattractants, such as VEGF, G-CSF and SDF-1α (68, 129, 134), however, 359 
mechanistic studies in exercise and EPC mobilization are lacking. 360 
 361 
It is not just single bouts of exercise which may have this profound effect on EPCs, but 362 
studies investigating the effect of regular exercise and physical activity on these cells 363 
generally report increases in EPC number and/or function (27, 52, 69, 122, 135-139), 364 
even in older adults (27, 52). After a 3-month home-based aerobic exercise intervention, 365 
older men, who had displayed significantly reduced basal EPC number and migratory 366 
function, improved their EPC number and function nearly 2-fold (52). Xia et al. (27) 367 
reported improvements in both in vitro and in vivo function of EPCs from older adults 368 
who had underwent a 12-week aerobic exercise program using a carotid artery injury 369 
mouse model. The researchers took EPCs from older adults before and after the exercise 370 
program, and injected these into the left carotid of athymic nude mice after inducing 371 
carotid injury. Endothelial regeneration was evaluated by measuring the area of re-372 
endothelialization in the denuded artery 3 days post-injection. The improvement 373 
observed in re-endothelialization due to EPCs from older individuals post-training was 374 
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accompanied by improvements in intracellular CXCR4 signalling, which is key for 375 
EPC homing to sites of injury (41).   376 
 377 
It is clear that single bouts and regular prolonged exercise can improve circulating 378 
number and function of these vasculogenic cells in humans, This improvement has been 379 
aligned to improvements in vascular function, and reduced arterial stiffness, offering a 380 
key mechanism by which exercise may benefit cardiovascular health in older 381 
populations. The potential effects of exercise and physical activity on EPCs in aging 382 
has been reviewed in depth elsewhere (67). 383 
 384 
Obesity 385 
 386 
Obesity is heavily linked with the development of key variables of the metabolic 387 
syndrome and type 2 diabetes mellitus (T2DM). The worldwide incidence of CVD and 388 
metabolic abnormalities, such as T2DM is increasing, and obesity is a significant risk 389 
factor. Data suggests that those who are overweight or obese are 50-75% more likely 390 
to develop CVD than those who are ‘normal weight’ (140). This is likely to be driven 391 
by inflammatory pathways, including adipose tissue-derived tumour necrosis factor-α 392 
(TNF-α) (141), which may affect endothelial function specifically via activation of 393 
NADPH oxidase and subsequent production of superoxide (142). Endothelial 394 
dysfunction with obesity precedes the development of atherosclerosis, with impaired 395 
vasodilator functions apparent (143), potentially as a direct result of impairments in the 396 
L-arginine-NO pathway. Therefore, obesity-induced endothelial dysfunction may be a 397 
primary cause of the increased CVD risk in this population. 398 
 399 
 17 
Obesity may promote endothelial dysfunction via effects on endothelial regeneration 400 
and repair mechanisms, such as bone marrow-derived EPCs. Fadini et al. (144) 401 
observed a negative association between components of the metabolic syndrome, and 402 
CD34+ progenitor cell count, with accumulative scores of the metabolic syndrome 403 
strengthening this inverse relationship. Several studies report inverse relationship 404 
between BMI and circulating total progenitor cells and EPC count (144, 145). 405 
Furthermore, other studies have reported that obese men with metabolic syndrome had 406 
40% fewer circulating EPCs than healthy age-matched controls (146). Interestingly, 407 
EPC proliferative capacity reflected reductions in circulating EPCs in obese compared 408 
to lean individuals (147). The same group showed that the in vitro pro-angiogenic 409 
function of EPCs was also impaired with obesity in 50+ year old individuals, with 410 
impaired stimulated release of both VEGF and G-CSF, which may be linked to the 411 
finding that these EPCs displayed higher expression of caspase-3, a pro-apoptotic 412 
intracellular signal (148). In a murine model of obesity, obese animals displayed 413 
impaired in vitro angiogenesis, suppressed EPC mobilization in response to limb 414 
ischemia, and reduced incorporation into aortic vessels after LPS-induced vascular 415 
damage (149), confirmed by other animal models also showing impaired recovery of 416 
blood flow after limb ischemia accompanying the reductions in ischemia-induced PC 417 
mobilization (150). In humans, EPC adhesion, migration and angiogenesis in vitro were 418 
significantly lower than lean individuals (151). The ability of EPCs to home to sites of 419 
ischemia, adhere and migrate are key roles of EPCs in order for these cells to exert their 420 
vasculogenic function. These findings suggest that obesity suppresses the angiogenic 421 
potential of human EPCs to home to sites of vascular damage or tissue ischemia, and 422 
to promote blood vessel growth and repair. 423 
 424 
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There is clear evidence for obesity-mediated EPC dysfunction, which may be as a result 425 
of associated inflammation, impaired glucose tolerance and elevated oxidative stress. 426 
The resultant endothelial dysfunction and suppressed endothelial repair capacity 427 
increases the risk of atherosclerosis in this population. Interventions designed to 428 
stimulate weight loss may have significant health benefits by improving vascular 429 
endothelial health via modulating EPC number and functional capacity. 430 
 431 
Calorie Restriction/Weight Loss Dietary Interventions to Combat 432 
Obesity-Mediated EPC Dysfunction 433 
 434 
Recently, calorie restriction diets have been touted as a potential intervention to 435 
improve health and enhance longevity (152). Recent reports suggest that calorie 436 
restriction may reduce CVD risk through modulating oxidative stress levels (153), and 437 
DNA damage (154). Such diets have been proven to be beneficial for weight loss in 438 
overweight and obese individuals (155, 156) due to the stark effects on reducing 439 
oxidative stress (157) and improving the metabolic profile of obese and older humans 440 
(156, 158-160).  441 
 442 
A 24-week low carbohydrate diet resulted in significant reductions in endothelial 443 
damage biomarkers in overweight post-menopausal women despite no changes in 444 
metabolic profiles (161), suggesting vascular benefit effect of such a diet is independent 445 
of metabolic changes. Added to this, there is a wealth of evidence showing vascular 446 
function benefits of calorie restriction/weight loss diets in obese and older individuals 447 
(162-168). Mechanisms include reductions in NADPH oxidase activity, increased 448 
activation of sirtuin-1, a powerful intracellular antioxidant complex (169), increased 449 
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antioxidant capacity (increased levels of manganese superoxide dismutase) and 450 
increasing tissue eNOS content and NO bioavailability (170). Furthermore, 451 
improvements in vascular function with weight loss strategies may be preceded by 452 
improvements in endothelial regenerative capacity. 453 
 454 
Indeed, preliminary data showed that weight loss strategies may be beneficial for 455 
improving EPC number (171). The extent of reductions in body fat composition in 456 
response to a weight loss diet relate to the extent of EPC improvement in humans (172). 457 
Xin et al. (173) exposed mice to prolonged fasting after cerebral ischemia. They 458 
observed significant upregulation of the antioxidant enzyme MnSOD,  as well as eNOS 459 
in bone marrow-derived EPCs, increased capillary number in the infarct zone, and 460 
improved EPC migratory and tube formation capacity in the fasted mice compared to 461 
control mice. These observations were accompanied by reductions in volume of infarct 462 
zone, which was also further improved by intravenous administration of EPCs from 463 
fasted mice compared to control mice (173), strongly suggesting protective role of 464 
periodic fasting to improve EPC vascular regenerative capacity. Interestingly, exercise 465 
and diet may act synergistically to promote EPC number and function in obese 466 
populations (174). An 8-week combined exercise and calorie restricted diet resulted in 467 
significant improvements in circulating EPCs, and EPC migratory capacity in obese 468 
populations (174). However, the effect of combined strategies in older adults is yet to 469 
be investigated but may hold promise due to the already significant impact of exercise 470 
on EPC number and function (49, 54, 128). 471 
 472 
Future Directions 473 
 20 
Currently, large-scale cohort interventional studies in dietary influence on vascular 474 
regenerative capacity are lacking, especially in aging adults with or without CVD, and 475 
are thus warranted. In addition, other angiogenic cell populations, such as angiogenic 476 
T-cells (175, 176), mesenchymal stem/progenitor cells (177) are being investigated for 477 
their influence of endothelial function through their potent pro-angiogenic capacity, and 478 
may be targets for such therapeutic interventions, such as diet and/or exercise.  479 
Additionally, the role of physical activity and exercise for cardiovascular benefit is 480 
clear, however, more studies are required to elucidate the benefit for older, and frail 481 
populations who are specifically at-risk of CVD and vascular-related disorders. 482 
 483 
[INSERT FIGURE 2 HERE] 484 
 Summary 485 
Age-related increased CVD risk is due to a plethora of factors. Reductions in 486 
endothelial repair capacity via alterations in both EPC number and functions may 487 
explain the aging impairments in endothelial function, thus promoting atherosclerotic 488 
disease risk. However, lifestyle factors such as diet, exercise and obesity (Figure 2) can 489 
have a significant impact on these vascular regenerative cells, and thus older 490 
populations may be able to attenuate CVD risk through lifestyle modifications.  491 
 492 
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Figure 1. Effect of Aging on Circulating Endothelial Progenitor Cell Number and 1113 
Vasculogenic Function. 1114 
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Figure 2. Possible Effects of Lifestyle Factors on Aging Circulating Endothelial 1136 
Progenitors and Cardiovascular Risk. 1137 
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Tables 1149 
Table 1. Influence of Age on Circulating Endothelial Progenitor Cell Number and Function. 1150 
Reference Subjects EPC Assay Findings 
Xia et al., 2012a 
(21) 
10 young, 10 older males.  Flow cytometry 
CD34+VEGFR2+ 
EPC migration and adhesion 
Human EPC re-endothelialization in mice 
Lower CD34+VEGFR2+ cells in elderly. 
Reduced migration, adhesion and re-endothelialization capacity in 
elderly vs. young males. 
Xia et al., 2012b 
(27) 
25 young, 22 elderly males. 
Resting  
Flow cytometry 
CD34+VEGFR2+/CD133+VEGFR2+ 
EPC migration and adhesion 
Human EPC re-endothelialization in mice 
Lower CD34+VEGFR2+/ CD133+VEGFR2+ cells in elderly. 
Reduced migration, adhesion and re-endothelialization capacity in 
elderly vs. young males. 
Thijssen et al., 2006 
(49) 
8 young, 8 older sedentary 
males. 
Flow cytometry 
CD34+VEGFR2+ 
Lower CD34+VEGFR2+ EPCs in older vs. younger males 
Thum et al., 2007 
(50) 
10 young, 16 middle-aged, 
12 older males.  
Flow cytometry 
CD133+VEGFR2+ 
EPC migration and eNOS gene expression. 
Lower EPC number and migration in older vs. middle-aged and 
younger males. 
Lower EPC eNOS gene expression in older vs. younger adults.  
Heiss et al., 2005 
(51) 
20 young and 20 older male 
and female subjects.  
Flow cytometry 
CD34+VEGFR2+/CD133+VEGFR2+ 
EPC survival, migration and proliferation assays. 
No difference in EPC number between young and older subjects. 
Lower survival, migration and proliferation of EPCs in older 
subjects. 
Hoetzer et al., 2007 
(52) 
10 young, 15 middle-aged, 
21 older men.  
EPC EC-CFU assay. 
EPC migration 
Lower EC-CFU in older and middle-aged adults compared to 
young subjects. 
Lower migration of EPCs from older subjects vs. middle-aged and 
younger adults. 
EPC- Endothelial Progenitor Cells, eNOS- endothelial nitric oxide synthase, EC-CFU- Endothelial Cell Colony-Forming Units. 1151  1152 
 1153 
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Table 1. Influence of Age on Circulating Endothelial Progenitor Cell Number and Function (Continued). 1155 
Reference Subjects EPC Assay Findings 
Williamson et al. 
2013 (53) 
EPCs from 5 young, and 4 
older subjects. 
EPC apoptosis, migration, and tube formation 
assays 
No difference in proliferation, apoptosis and tube 
formation of EPCs from young and older subjects. 
EPC migration lower in older subjects vs. younger 
subjects. 
Ross et al., 2018 
(54) 
107 males, aged 18-75yrs. 
 
Flow cytometry 
CD34+CD45dimVEGFR2+ 
Cell surface expression of CXCR4 
Age inversely associated with EPC number and cell 
surface CXCR4 expression. 
Yang et al., 2013 
(55) 
10 young, 10 older male 
subjects. 
Flow cytometry: CD34+VEGFR2+ 
EPC migration and proliferative assays. 
Lower EPC number, migration and proliferation in older 
vs. younger subjects. 
 
Kushner et al., 2009 
(56) 
12 young, 12 middle-aged, 
and 16 older sedentary males. 
EPC telomere length Lower EPC telomere length in older vs. middle-aged and 
younger males. 
Kushner et al., 2010 
(57) 
17 young and 20 older males. Stimulated release of EPC-derived pro-
angiogenic cytokines and growth factors 
Lower release of G-CSF from EPCs from older vs. 
younger subjects. 
EPC- Endothelial Progenitor Cells, CXCR4- C-X-C Chemokine Receptor 4. 1156 
 1157 
